Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-16T08:42:35.331Z Has data issue: false hasContentIssue false
  • English
  • Français

Coronavirus disease 2019: changing the future of emergency epistaxis management

Part of: JLO Coronavirus Collection

Published online by Cambridge University Press:  18 May 2021

Y Devabalan ,
N Cereceda-Monteoliva ,
H Lorenz ,
J C Magill ,
S Unadkat ,
M Ferguson  and
C Rennie
Y Devabalan*
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
N Cereceda-Monteoliva
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
H Lorenz
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
J C Magill
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
S Unadkat
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
M Ferguson
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
C Rennie
Affiliation:
Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
*
Author for correspondence: Mr Yadsan Devabalan, Department of Otorhinolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Rd, Hammersmith, LondonW6 8RF, UK Email: yadsan.devabalan@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach.

Methods

A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction.

Results

A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (p = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all p < 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible.

Conclusion

The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens.

Keywords

EpistaxisHemostasisPatient Reported Outcome Measures
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 8 , August 2021 , pp. 675 - 679
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Mr Y Devabalan takes responsibility for the integrity of the content of the paper

References

National ENT Trainee Research Network. Epistaxis 2016: national audit of management. J Laryngol Otol 2017;131:1131–41CrossRefGoogle Scholar
National ENT Trainee Research Network. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis. J Laryngol Otol 2017;131:1142–56CrossRefGoogle Scholar
Pope, LE, Hobbs, CG. Epistaxis: an update on current management. Postgrad Med J 2005;81:309–14CrossRefGoogle ScholarPubMed
Cohen, O, Shoffel-Havakuk, H, Warman, M, Tzelnick, S, Haimovich, Y, Kohlberg, GD et al. Early and late recurrent epistaxis admissions: patterns of incidence and risk factors. J Otolaryngol Head Neck Surg 2017;157:424–3110.1177/0194599817705619CrossRefGoogle ScholarPubMed
ENTUK. ENTUK Guidelines for changes in ENT during COVID-19 Pandemic. In: https://www.entuk.org/entuk-guidelines-changes-ent-during-covid-19-pandemic [2 March 2021]Google Scholar
ENTUK. Guidance for ENT during the COVID-19 pandemic. In: https://www.entuk.org/guidance-ent-during-covid-19-pandemic [2 March 2021]Google Scholar
Thamboo, A, Lea, J, Sommer, DD, Sowerby, L, Abdalkhani, A, Diamond, C et al. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology–head and neck surgery during the COVID-19 pandemic. J Otolaryngol Head Neck Surg 2020;49:28CrossRefGoogle ScholarPubMed
Iqbal, IZ, Jones, GH, Dawe, N, Mamais, C, Smith, ME, Williams, RJ et al. Intranasal packs and haemostatic agents for the management of adult epistaxis: systematic review. J Laryngol Otol 2017;131:1065–9210.1017/S0022215117002055CrossRefGoogle ScholarPubMed
Pallin, DJ, Chng, Y-M, McKay, MP, Emond, JA, Pelletier, AJ, Camargo, CA. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med 2005;46:77–81CrossRefGoogle ScholarPubMed
Gov.uk. Major new measures to protect people at highest risk from coronavirus 2020. In: https://www.gov.uk/government/news/major-new-measures-to-protect-people-at-highest-risk-from-coronavirus [4 March 2021]Google Scholar
ENTUK. COVID-19 epistaxis management. In: https://www.entuk.org/sites/default/files/files/COVID%2019%20Epistaxis%20Management.pdf [14 May 2021]Google Scholar
James, H, Papoutsi, C, Wherton, J, Greenhalgh, T, Shaw, SE. Spread, scale-up and sustainability of video consulting in health care: a systematic review and synthesis guided by the NASSS framework. J Med Internet Res 2021;23:e23775CrossRefGoogle ScholarPubMed
Hartnett, KP, Kite-Powell, A, DeVies, J, Coletta, MA, Boehmer, TK, Adjemian, J et al. Impact of the COVID-19 pandemic on emergency department visits - United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:699–704CrossRefGoogle ScholarPubMed
Nuffield Trust. Where are the patients? The factors affecting the use of emergency care during COVID-19. In: https://www.nuffieldtrust.org.uk/news-item/where-are-the-patients-the-factors-affecting-the-use-of-emergency-care-during-covid-19 [5 March 2021]Google Scholar
Wang, J, Cai, C, Wang, S. Merocel versus Nasopore for nasal packing: a meta-analysis of randomized controlled trials. PLoS One 2014;9:e93959CrossRefGoogle ScholarPubMed
Milinis, K, Swords, C, Hardman, J, Slovick, A, Hutson, K, Kuhn, I et al. Dissolvable intranasal haemostatic agents for acute epistaxis: a systematic review and meta-analysis. Clin Otolaryngol 2021;46:485–93CrossRefGoogle ScholarPubMed
Mathiasen, RA, Cruz, RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 2005;115:899–902CrossRefGoogle ScholarPubMed
Le, A, Thavorn, K, Lasso, A, Kilty, SJ. Economic evaluation of Floseal compared to nasal packing for the management of anterior epistaxis. Laryngoscope 2018;128:1778–82CrossRefGoogle ScholarPubMed
Murray, S, Mendez, A, Hopkins, A, El-Hakim, H, Jeffery, CC, Côté, DWJ. Management of persistent epistaxis using Floseal hemostatic matrix vs. traditional nasal packing: a prospective randomized control trial. J Otolaryngol Head Neck Surg 2018;47:3CrossRefGoogle ScholarPubMed
Van Wyk, F, Massey, S, Worley, G, Brady, S. Do all epistaxis patients with a nasal pack need admission? A retrospective study of 116 patients managed in accident and emergency according to a peer reviewed protocol. J Laryngol Otol 2007;121:222–7CrossRefGoogle ScholarPubMed
Hardman, JC, INTEGRATE (The UK ENT Trainee Research Network). Admission avoidance in acute epistaxis: a prospective national audit during the initial peak of the COVID-19 pandemic. Clin Otolaryngol 2021;46:577–86CrossRefGoogle Scholar
Badran, K, Malik, TH, Belloso, A, Timms, MS. Randomized controlled trial comparing Merocel and RapidRhino packing in the management of anterior epistaxis. Clin Otolaryngol 2005;30:333–7CrossRefGoogle ScholarPubMed
Kastl, KG, Reichert, M, Scheithauer, MO, Sommer, F, Kisser, U, Braun, T et al. Patient comfort following FESS and Nasopore® packing, a double blind, prospective, randomized trial. Rhinology 2014;52:60–5CrossRefGoogle ScholarPubMed